J Med Cases
Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website http://www.journalmc.org

Case Report

Volume 9, Number 4, April 2018, pages 122-124


A Case Report of Thyroid Gland Metastasis in Small Cell Lung Cancer

Shiqiang Yang

Xintai Hospital Affiliated to Taishan Medical University, No. 1329 Xinfu Road, Xintai, Tai’an City, China

Manuscript submitted March 5, 2018, accepted March 22, 2018
Short title: Thyroid Metastasis of Small Cell Lung Cancer
doi: https://doi.org/10.14740/jmc3031w

Abstract▴Top 

Thyroid metastasis of small cell lung cancer is rare in clinic, and few cases have been reported so far. We reported one case of 61-year-old Chinese male patient who presented with a progressive enlargement of mass in the right thyroid gland for 1 month. It was confirmed later to be originating from a small cell lung cancer. Then the patient was given chemoradiotherapy, but still died 6 months later. Although thyroid gland metastasis in lung cancer is rare in clinic, it should not be misdiagnosed. The treatment of thyroid metastasis of small cell lung cancer is mainly chemoradiotherapy; long-term survival of thyroid metastasis remained worse.

Keywords: Thyroid gland metastasis; Small cell lung cancer; Neoplasm metastasis

Introduction▴Top 

Primary bronchogenic carcinoma is one of the most common malignant tumors. The incidence and mortality of lung cancer all over the world are rising, especially in developing countries such as China [1]. According to the cancer statistics in China 2015 [2], the incidence and mortality of lung cancer were 17.09% and 21.68%, respectively. It has a propensity to metastasize to any organ. It often metastasizes to the brain, bone, liver, lung, adrenal gland, etc. The metastases of lung cancer to the thyroid gland are rare [3]. Of the four types of lung cancer causing thyroid gland metastasis, adenocarcinomas are the commonest followed by squamous and large cell carcinomas. The metastasis of small cell lung cancer to the thyroid gland is rarely reported [4]. The purpose of this report is to present thyroid gland metastasis of a small cell lung cancer, as the first site of metastasis, originally misdiagnosed as thyroid carcinoma, confirmed to be originating from a small cell lung cancer.

Case Report▴Top 

A 61-year-old Chinese male was admitted to our hospital for progressive right thyroid enlargement for 1 month. The patient had been a smoker of 20 cigarettes per day for over 40 years, sometimes complained of cough and expectoration but did not complain other symptoms related to lung cancer. Thyroid ultrasound examination showed there to be a hypoechoic nodule with a size of 4.1 × 2.6 cm (Fig. 1). Therefore, we first diagnosed it as a primary thyroid carcinoma. A fine needle aspiration (FNA) revealed clusters of malignant epithelial. Immunohistochemistry showed thyroid transcription factor-1 ( TTF-1) (+), synaptophysin (Syn ) (+), actin (-), S-100 (-), P63 (-), epithelial membrane antigen (EMA) (-), cytokeratin 20 (CK 20 ) (-) (Fig. 2). Then, we did the chest computed tomography (CT) examination; CT scan revealed a shadow in the right upper lobe, with a size of approximately 5.4 × 6.3 cm (Fig. 3). The diagnosis of small cell lung cancer was followed by fiberoptic bronchoscopy. Then chemotherapy protocol of etoposide 100 mg/m2 D1 - 3 and cisplatin 75 mg/m2 D1 was performed. After two cycles of chemotherapy, the external radiotherapy was given. After 6 months, the patient died of respiratory failure.

Figure 1.
Click for large image
Figure 1. Thyroid ultrasound examination showed a hypoechoic nodule with the size of 4.1× 2.6 cm.

Figure 2.
Click for large image
Figure 2. Immunohistochemistry showed thyroid transcription factor-1 (TTF-1) (+) (×100).

Figure 3.
Click for large image
Figure 3. Chest computed tomography (CT) examination scan revealed a shadow in the right upper lobe, with a size of approximately 5.4 × 6.3 cm.
Discussion▴Top 

The thyroid gland is at risk for tumor metastases from distant sites because of its rich vascular supply [5]. Metastases from other malignant tumors to the thyroid gland are an uncommon clinical presentation. In autopsy, primary lung cancer is a common part of thyroid gland metastases. In clinical treatment, renal cell carcinoma is the most common primary site, followed by breast cancer and gastrointestinal malignancies. Of the lung cancer known to metastasize to the thyroid, non-small cell lung cancer is the most common type. There are only a few reported cases of thyroid metastases in small cell lung cancer [6, 7]. The diagnosis of small cell lung cancer sometimes is made from metastatic lesions.

We report a case of thyroid metastasis as the first symptom. Small cell carcinoma was determined by FNA biopsy and the thyroid metastasis of small cell lung cancer was confirmed by chest CT examination. The pathology can be confirmed by FNA of the thyroid gland. Studies have shown that the sensitivity rate of thyroid FNA biopsy to the diagnosis of thyroid metastases is 83% (range 65 to 98%) [8]. Chung et al estimated that thyroid gland FNA biopsy provide the correct diagnosis in 73.7% of all patients [5]. FNA biopsy of thyroid gland is difficult to differentiate between primary thyroid carcinoma and highly differentiated metastatic carcinoma.

Thyroid metastasis of small cell lung cancer is not recommended for thyroidectomy. The clinical treatment recommended chemotherapy with cisplatin and etoposide, or chemotherapy and radiotherapy. Osawa et al [4] reported a case of small cell lung cancer underwent chemotherapy consisting of cisplatin and etoposide, followed by prophylactic cranial irradiation. Four years later, a thyroid metastasis was diagnosed then followed by thyroidectomy. After adjuvant chemotherapy, the patient has been disease-free for over 1 year. After the occurrence of thyroid metastasis, it thought to indicate poor prognosis. With the improvement of the treatment modalities, the survival of the patients was increased to 9 and 18 months. Calzolari et al reported that the survival of single metastases of thyroid were superior to multiple metastases [9].

With the increasing application of imaging technology, such as positron emission tomography, FNA biopsy of thyroid, and the longer survival of tumor patients, thyroid metastatic diseases will be more frequent.

In view of our clinical case report, we suggest that the metastases of small cell lung cancer to the thyroid gland are rare. The clinical diagnosis requires FNA biopsy of the thyroid gland. The primary tumor was small cell lung cancer then etoposide and cisplatin treatment protocol was start, and external radiotherapy was given. The patient died 6 months after the diagnosis, shorter than expected. It is necessary to optimize treatment protocol.

Conclusions

Although thyroid gland metastasis in small cell lung cancer is extremely rare, a potential metastasis of small cell lung cancer should not be ignored in the diagnosis of thyroid tumor. However long-term survival of thyroid metastasis remained worse. The treatment protocol needs to be improved.

Financial Support

Funded by the scientific research department of the Xintai People’s Hospital


References▴Top 
  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
    doi pubmed
  2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-132.
    doi pubmed
  3. Hulikal N, Naru RR, Gangasani R, Nandyala R, Pai A, Meenakshisundaram M. A case of synchronous isolated thyroid metastasis from a primary lung cancer presenting as thyroid primary: Diagnostic challenge! Lung India. 2016;33(3):326-329.
    doi pubmed
  4. Osawa M, Takigawa N, Kiura K, Ichimura K, Matsuoka J, Hotta K, Tabata M, et al. Isolated metastasis of lung cancer to the thyroid gland. Lung Cancer. 2007;58(1):156-158.
    doi pubmed
  5. Chung AY, Tran TB, Brumund KT, Weisman RA, Bouvet M. Metastases to the thyroid: a review of the literature from the last decade. Thyroid. 2012;22(3):258-268.
    doi pubmed
  6. Katsenos S, Archondakis S, Vaias M, Skoulikaris N. Thyroid gland metastasis from small cell lung cancer: an unusual site of metastatic spread. J Thorac Dis. 2013;5(2):E21-24.
    pubmed
  7. Ozgu ES, Gen R, Ilvan A, Ozge C, Polat A, Vayisoglu Y. Small cell lung cancer with metastasis to the thyroid in a patient with toxic multinodular goiter. J Craniofac Surg. 2012;23(6):e614-615.
    doi pubmed
  8. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, Vitti P, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2010;16(Suppl 1):1-43.
    doi pubmed
  9. Calzolari F, Sartori PV, Talarico C, Parmeggiani D, Beretta E, Pezzullo L, Bovo G, et al. Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Res. 2008;28(5B):2885-2888.
    pubmed


This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Medical Cases is published by Elmer Press Inc.

 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.